References
- Donato J, Wasinski F, Furigo IC, et al. Central regulation of metabolism by growth hormone. Cells. 2021;10(1):129–135.
- Vyas V, Menon RK. Management of short stature: use of growth hormone in GH-deficient and non-GH-Deficient Conditions. Indian J Pediatr. 2021;88(12):1203–1208.
- Shepherd S, Saraff V, Shaw N, et al. Growth hormone prescribing patterns in the UK, 2013–2016. Arch Dis Child. 2019;104(6):583–587.
- Mohseni S, Heydari Z, Qorbani M, et al. Adherence to growth hormone therapy in children and its potential barriers. J Pediatr Endocrinol Metab. 2018;31(1):13–20.
- Miller BS, Velazquez E, Yuen KC. Long-acting growth hormone preparations–current status and future considerations. J Clin Endocrinol Metabol. 2020;105(6):e2121–e2133.
- Mathias NR, Hussain MA. Non-invasive systemic drug delivery: developability considerations for alternate routes of administration. J Pharm Sci. 2010;99(1):1–20.
- Anselmo AC, Gokarn Y, Mitragotri S. Non-invasive delivery strategies for biologics. Nat Rev Drug Discov. 2019;18(1):19–40.
- de Araujo DR, Ribeiro LNdM, de Paula E. Lipid-based carriers for the delivery of local anesthetics. Expert Opin Drug Deliv. 2019;16(7):701–714.
- Chime SA, Onyishi IV. Lipid-based drug delivery systems (LDDS): recent advances and applications of lipids in drug delivery. Afr J Pharm Pharmacol. 2013;7(48):3034–3059.
- Ijaz H, Qureshi J, Tulain UR, et al. Lipid particulate drug delivery systems: a review. Bioinspired, Biomimetic Nanobiomater. 2018;7(2):109–121.,
- Rabiei M, Kashanian S, Samavati SS, et al. Nanomaterial and advanced technologies in transdermal drug delivery. J Drug Target. 2020;28(4):356–367.,
- Ahmad S, Teotia D, Kumar K. Niosomes-A PromisingCarrier for drug delivery. IJRDPL. 2018;7(4):3015–3021.
- Yeo PL, Lim CL, Chye SM, et al. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomed. 2018;11(4):301–314.
- Moghassemi S, Parnian E, Hakamivala A, et al. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. Mater Sci Eng C Mater Biol Appl. 2015;46:333–340.
- Wu T, Zhu C, Wang X, et al. Cholesterol and phospholipid-free multilamellar niosomes regulate transdermal permeation of a hydrophobic agent potentially administrated for treating diseases in deep hair follicles. J Pharm Sci. 2021.
- Salem HF, Kharshoum RM, Abou-Taleb HA, et al. Fabrication and appraisal of simvastatin via tailored niosomal nanovesicles for transdermal delivery enhancement: in vitro and in vivo assessment. Pharmaceutics. 2021;13(2):138–145.
- Shah H, Nair AB, Shah J, et al. Proniosomal vesicles as an effective strategy to optimize naproxen transdermal delivery. J Drug Deliv Sci Technol. 2021;63:102479.
- Nemr AA, El-Mahrouk GM, Badie HA. Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application. Drug Dev Ind Pharm. 2021;47(3):403–415.
- Shah HS, Gotecha A, Jetha D, et al. Gamma oryzanol niosomal gel for skin cancer: formulation and optimization using quality by design (QbD) approach. AAPS Open. 2021;7(1):1–15.
- Garg AK, Maddiboyina B, Alqarni MHS, et al. Solubility enhancement, formulation development and antifungal activity of luliconazole niosomal gel-based system. J Biomater Sci Polym Ed. 2021;32(8):1009–1023.
- E WS, Jaworowicz D, Shahzamani A, et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med. 1996;2(7):795–799. −
- Lee JW, Choi SO, Felner EI, et al. Dissolving microneedle patch for transdermal delivery of human growth hormone. Small. 2011;7(4):531–539.
- Kateh Shamshiri M, Momtazi-Borojeni AA, Khodabandeh Shahraky M, et al. Lecithin soybean phospholipid nano-transfersomes as potential carriers for transdermal delivery of the human growth hormone. J Cell Biochem. 2019;120(6):9023–9033.
- Song Y, Hemmady K, Puri A, et al. Transdermal delivery of human growth hormone via laser-generated micropores. Drug Deliv and Transl Res. 2018;8(2):450–460.
- Levin G, Gershonowitz A, Sacks H, et al. Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res. 2005;22(4):550–555.
- Yang J-A, Kim E-S, Kwon JH, et al. Transdermal delivery of hyaluronic acid - human growth hormone conjugate. Biomaterials. 2012;33(25):5947–5954.,
- Sharma A, Kumar L, Kumar P, et al. Niosomes: a promising approach in drug delivery systems. J Drug Del Therapeutics. 2019;9(4):635–642.
- Yeo LK, Olusanya TO, Chaw CS, et al. Brief effect of a small hydrophobic drug (cinnarizine) on the physicochemical characterisation of niosomes produced by thin-film hydration and microfluidic methods. Pharmaceutics. 2018;10(4):185–195.
- Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328(2):130–141.
- Ning M, Guo Y, Pan H, et al. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats. Drug Del. 2005;12(6):399–407.
- Hamed R, Al Baraghthi T, Alkilani AZ, et al. Correlation between rheological properties and in vitro drug release from penetration enhancer-loaded carbopol® gels. J Pharm Innov. 2016;11(4):339–351.
- Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 2010;4(4):227–210.
- Said M, Aboelwafa AA, Elshafeey AH, et al. Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole. J Drug Del Sci Technol. 2021;61:102075.
- Fornasier M, Biffi S, Bortot B, et al. Cubosomes stabilized by a polyphosphoester-analog of pluronic F127 with reduced cytotoxicity. J Colloid Interface Sci. 2020;580:286–297.
- Kumbhar D, Wavikar P, Vavia P. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS Pharmscitech. 2013;14(3):1072–1082.
- Rosenthal AJ. Texture profile analysis–how important are the parameters? J Texture Stud. 2010;41(5):672–684.
- Nishinari K, Kohyama K, Kumagai H, et al. Parameters of texture profile analysis. FSTR. 2013;19(3):519–521.,
- Li Y, Wang D, Lu S, et al. Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro-mechanism. Eur J Pharm Sci. 2018;124:80–88.
- Erickson RL, Blevins CE, Souza Dyer CD, et al. Alfaxalone-xylazine anesthesia in laboratory mice (Mus musculus). J Am Assoc Lab Anim Sci. 2019;58(1):30–39.
- Juluri A, Peddikotla P, Repka MA, et al. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. J Pharm Sci. 2013;102(2):500–507.
- Fardous J, Yamamoto E, Omoso Y, et al. Development of a gel-in-oil emulsion as a transdermal drug delivery system for successful delivery of growth factors. J Biosci Bioeng. 2021;132(1):95–101.
- Manikkath J, Sumathy T, Manikkath A, et al. Delving deeper into dermal and transdermal drug delivery: factors and mechanisms associated with nanocarrier-mediated strategies. Curr Pharm Des. 2018;24(27):3210–3222.
- Jain A, Jain P, Kurmi J, et al. Novel strategies for effective transdermal drug delivery: a review. Crit Rev Therap Drug Carrier Syst. 2014;31(3):219–272.
- Owodeha-Ashaka K, Ilomuanya MO, Iyire A. Evaluation of sonication on stability-indicating properties of optimized pilocarpine hydrochloride-loaded niosomes in ocular drug delivery. Prog Biomater. 2021;10(3):207–220.
- Fayed ND, Goda AE, Essa EA, et al. Chitosan-encapsulated niosomes for enhanced oral delivery of atorvastatin. J Drug Del Sci Technol. 2021;66:102866.
- Nowroozi F, Almasi A, Javidi J, et al. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iranian J Pharmaceut Res. 2018;17(Suppl2):1–10.
- Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS Pharmscitech. 2010;11(3):1119–1127.
- Shah R, Eldridge D, Palombo E, et al. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci. 2014;25(1):59–75.
- Kim J-K, Lawler DF. Characteristics of zeta potential distribution in silica particles. Bull Korean Chem Soc. 2005;26(7):1083–1089.
- Eldeeb AE, Salah S, Ghorab M. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv. 2019;26(1):509–521.
- Mirzaie A, Peirovi N, Akbarzadeh I, et al. Preparation and optimization of ciprofloxacin encapsulated niosomes: a new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus. Bioorg Chem. 2020;103:104231.
- Govardhan C, Khalaf N, Jung CW, et al. Novel long-acting crystal formulation of human growth hormone. Pharm Res. 2005;22(9):1461–1470.
- Agarwal S, Bakshi V, Vitta P, et al. Effect of cholesterol content and surfactant HLB on vesicle properties of niosomes. Indian J Pharmaceutical Sci. 2004;66(1):121–131.
- Rapalli VK, Banerjee S, Khan S, et al. QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Mater Sci Eng C Mater Biol Appl. 2021;119:111548.
- Zhang L, Zhang J, Ling Y, et al. Sustained release of melatonin from poly (lactic-co-glycolic acid) (PLGA) microspheres to induce osteogenesis of human mesenchymal stem cells in vitro. J Pineal Res. 2013;54(1):24–32.
- Fazil M, Hassan MQ, Baboota S, et al. Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis. Drug Deliv. 2016;23(7):2428–2438.
- Fernandes M, Simon L, Loney NW. Mathematical modeling of transdermal drug-delivery systems: Analysis and applications. J Membr Sci. 2005;256(1–2):184–192.
- Ishii S, Ishii K, Nakadate M, et al. Correlation study in skin and eye irritation between rabbits and humans based on published literatures. Food Chem Toxicol. 2013;55:596–601.
- Biju S, Talegaonkar S, Mishra P, et al. Vesicular systems: an overview. Indian J Pharm Sci. 2006;68(2):141–110.,